Alnylam Pharmaceuticals Inc (ALNY)
NASDAQ · Healthcare
Alnylam Pharmaceuticals Inc Gross Profit 2008–2025
Alnylam Pharmaceuticals Inc annual/quarterly gross profit history and growth rate from 2017 to 2025. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Alnylam Pharmaceuticals Inc gross profit for the quarter ending September 30, 2025 was 1.1 B, a 151.06% increase year-over-year.
- Alnylam Pharmaceuticals Inc gross profit for the twelve months ending September 30, 2025 was 2.6 B, a 34.91% increase year-over-year.
- Alnylam Pharmaceuticals Inc annual gross profit for 2025 was 3.0 B, a 56.40% increase from 2024.
- Alnylam Pharmaceuticals Inc annual gross profit for 2024 was 1.9 B, a 24.46% increase from 2023.
- Alnylam Pharmaceuticals Inc annual gross profit for 2023 was 1.6 B, a 73.87% increase from 2022.
- Alnylam Pharmaceuticals Inc annual gross profit for 2022 was 897.2 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Alnylam Pharmaceuticals Inc Gross Profit — FAQ
Alnylam Pharmaceuticals Inc (ALNY) gross profit over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
What is Alnylam Pharmaceuticals Inc's gross profit?
Alnylam Pharmaceuticals Inc (ALNY) reported gross profit of $3.04B for fiscal 2025.
Where can I see ALNY's gross profit history?
The chart and table above show Alnylam Pharmaceuticals Inc's gross profit by year and by quarter, including the growth rate.